Sign In
Buy REGN
$618.95
+16.03 (+2.66%)
At Close: Jun 03, 2026
Top 5 High ROE Stocks to Buy as Fed Tapering Looms Large
10:43am, Thursday, 28'th Oct 2021
Seagate Technology (STX), Best Buy (BBY), Celanese Corporation (CE), CBRE Group (CBRE), and Regeneron Pharmaceuticals (REGN) are some stocks with high ROE to buy as the Fed tapering decision is expect
Regeneron Looks Oversold, Ready To Jump Up On Catalysts
03:11am, Monday, 25'th Oct 2021
The stock price has corrected sharply in recent months against the backdrop of which a multiple contraction has occurred. I think the dip was driven by a) Cathie Wood's transactions and b) declining n
Major Stock Indexes Hit Record-High Level: 5 Top-Ranked Picks
08:43am, Friday, 22'nd Oct 2021
We have narrowed down our search to five stocks that are members of any of the three major stock indexes. These are: GS, XOM, CVX, COP and REGN.
Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know
07:18pm, Wednesday, 20'th Oct 2021
In the latest trading session, Regeneron (REGN) closed at $562.71, marking a +1.92% move from the previous day.
4 Top-Ranked Stocks to Invest in for Solid Earnings Growth
04:42pm, Monday, 18'th Oct 2021
Regeneron Pharmaceuticals (REGN), Evercore (EVR), Houlihan Lokey (HLI) & DICK'S Sporting Goods (DKS) currently have striking earnings growth and positive estimate revisions, which make them must-buys.
3 No-Brainer Biotech Stocks to Buy Right Now
06:04am, Saturday, 16'th Oct 2021
Regeneron Pharmaceuticals, Vertex Pharmaceuticals, and Viatris should have plenty of room to run.
2 Cheap Growth Stocks That Could Be Even Better Buys in November
06:10am, Friday, 15'th Oct 2021
Both of these companies are reporting earnings within the next month, and there could be a dip in price that follows.
Why Regeneron Shares Are Rising Today
10:28am, Thursday, 14'th Oct 2021
Regeneron Pharmaceuticals Inc (NASDAQ: REGN) is trading higher Thursday after the company announced the FDA accepted for priority review a Biologics License Application for REGEN-COV to treat COVID-1
Regeneron is seeking full FDA approval for its monoclonal antibody for two types of COVID-19 patients
07:50am, Thursday, 14'th Oct 2021
Shares of Regeneron Pharmaceuticals Inc. REGN, +0.49% gained 2.7% in premarket trading on Thursday after the company said the Food and Drug Administration accepted its application for approval of its
FDA Accepts REGEN-COV® (casirivimab and imdevimab) for Priority Review for Treatment and Prophylaxis of COVID-19
07:21am, Thursday, 14'th Oct 2021
TARRYTOWN, N.Y., Oct. 14, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for priority review a Bi
Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know
07:06pm, Wednesday, 13'th Oct 2021
In the latest trading session, Regeneron (REGN) closed at $547.12, marking a +0.49% move from the previous day.
Top 3 undervalued US biotech stocks to buy
02:27pm, Tuesday, 12'th Oct 2021
With the US Q3 earnings season just getting started, there are a few biotech stocks that present an exciting opportunity for value investors. Some of these stocks look significantly undervalued after
Regeneron to Report Third Quarter 2021 Financial and Operating Results and Host Conference Call and Webcast on November 4, 2021
04:15pm, Monday, 11'th Oct 2021
TARRYTOWN, N.Y., Oct. 11, 2021 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its third quarter 2021 financial and operating results on Thursday, N
Regeneron Could Have a Big Catalyst Coming in 2022
06:30am, Saturday, 09'th Oct 2021
Cancer drug Libtayo could receive FDA approval for its fourth indication in January.
3 Reasons Why Growth Investors Shouldn't Overlook Regeneron (REGN)
07:05pm, Friday, 08'th Oct 2021
Regeneron (REGN) is well positioned to outperform the market, as it exhibits above-average growth in financials.
